Dependence of clot structure and fibrinolysis on apixaban and clotting activator
Background: Anticoagulants prevent the formation of potentially fatal blood clots. Apixaban is a direct oral anticoagulant that inhibits factor (F)Xa, thereby impeding the conversion of prothrombin into thrombin and the formation of blood clots. Blood clots are held together by fibrin networks that...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2024-11-01
|
| Edice: | Research and Practice in Thrombosis and Haemostasis |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2475037924003091 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|